SCHEMBL256698

SCHEMBL256698

CCc1ccn(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL27707721 0.93 DDB1 (0.42)
SCHEMBL28018436 0.88 EPHX2 (0.41)
SCHEMBL294282 0.81
Benzoic Acid SCHEMBL28017886 0.80 TSHR (0.48)
SCHEMBL324166 0.80
SCHEMBL15920605 0.78
SCHEMBL348762 0.78
SCHEMBL5140933 0.78
SCHEMBL1279845 0.78
Benzoyl Chloride SCHEMBL28017912 0.78 TSHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260175-A 5- (pyrazole-5-yl) -1,2,4-oxadiazole substituted benzamide compound and preparation method and application thereof 浙江工业大学 2022-11-01 CN claimed
CN-114920734-A 5- (pyrazole-5-yl) -1,2, 4-oxadiazole substituted benzamide compounds and preparation method and application thereof 浙江工业大学 2022-08-19 CN claimed
CN-106187894-A The preparation method of 1 methyl 3 ethyl 4 chlorine 5 pyrazole carboxylic acid ethyl ester 潍坊鑫诺化工有限公司 2016-12-07 CN claimed
US-7601871-B2 Ion exchanging; ionic liquids HONEYWELL INTERNATIONAL INC. (US) 2009-10-13 US claimed
US-20060247472-A1 Method for purifying quaternary onium salts HONEYWELL INTERNATIONAL INC. (US) 2006-11-02 US claimed
US-20260138970-A1 MODULATORS OF THE CALCIUM SIGNALING CASCADE FONDAZIONE TELETHON ETS (IT) 2026-05-21 US disclosed
US-20260092063-A1 FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF JAZZ PHARMACEUTICALS IRELAND LTD (IE) 2026-04-02 US disclosed
US-20260002028-A1 IONIC POLYMERS AND COPOLYMERS TWELVE BENEFIT CORPORATION (US) 2026-01-01 US disclosed
US-20250326748-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC (US) 2025-10-23 US disclosed
US-20250326773-A1 MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER KYORIN SEIYAKU KK (JP) 2025-10-23 US disclosed
US-20250326772-A1 MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER KYORIN SEIYAKU KK (JP) 2025-10-23 US disclosed
US-12421392-B2 Ionic polymers and copolymers TWELVE BENEFIT CORPORATION (US) 2025-09-23 US disclosed
US-20070197628-A1 Cannabinoid receptor modulators INTERVET INTERNATIONAL B.V. (NL) 2007-08-23 US disclosed
US-7247421-B2 Image forming method using photothermographic material FUJIFILM CORPORATION (JP) 2007-07-24 US disclosed
WO-2007036733-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2007-04-05 WO disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
CN-1302026-C Additional polymerization catalyst and its production process SUMITOMO CHEMICAL CO (JP) 2007-02-28 CN disclosed
WO-2007012421-A1 PIPERIDINYL-SUBSTITUTED ISOQUINOLONE DERIVATIVES AS RHO-KINASE INHIBITORS SANOFI-AVENTIS (DE) 2007-02-01 WO disclosed
CN-1390864-A Additional polymerization catalyst and its production process SUMITOMO CHEMICAL CO (JP) 2003-01-15 CN disclosed
CN-1315943-A Use of 5-amino-pyrazol-derivatives for combating micro-organisms BAYER AG (DE) 2001-10-03 CN disclosed